4d Molecular Therapeutics, Inc. · NASDAQ:FDMT

Bizily Scott sold 1,635 4d Molecular Therapeutics, Inc. shares (Form 4)

Traded Sep 16, 2026 · Filed Sep 22, 2026

On Sep 16, 2026, Bizily Scott (Chief Legal Officer) sold 1,635 4d Molecular Therapeutics, Inc. shares at US$13.65 for US$22,318 under a trading plan, leaving 8,617 shares. Filed Sep 22, 2026 (Form 4).

Sold
1,635 shares
Price
US$13.65
Value
US$22,318
Holding after
8,617 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Legal Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 16, 2026Common StockOption exercise1,635US$4.1410,252Direct
Sep 16, 2026Common StockSale1,635US$13.658,617Direct

Source

View original at SEC

Related